These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 19565622)

  • 1. Vitamin D in diabetes mellitus-a new field of knowledge poised for D-velopment.
    Alfonso B; Liao E; Busta A; Poretsky L
    Diabetes Metab Res Rev; 2009 Jul; 25(5):417-9. PubMed ID: 19565622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with adult-onset latent autoimmune diabetes (LADA).
    Li X; Liao L; Yan X; Huang G; Lin J; Lei M; Wang X; Zhou Z
    Diabetes Metab Res Rev; 2009 Jul; 25(5):411-6. PubMed ID: 19488999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopathological and genetic features in slowly progressive insulin-dependent diabetes mellitus and latent autoimmune diabetes in adults.
    Kobayashi T; Tanaka S; Harii N; Aida K; Shimura H; Ohmori M; Kanesige M; Shimada A; Maruyama T
    Ann N Y Acad Sci; 2006 Oct; 1079():60-6. PubMed ID: 17130533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D analogues in insulin-dependent diabetes mellitus and other autoimmune diseases: a therapeutic perspective.
    Mauricio D; Mandrup-Poulsen T; Nerup J
    Diabetes Metab Rev; 1996 Apr; 12(1):57-68. PubMed ID: 8861501
    [No Abstract]   [Full Text] [Related]  

  • 5. [Latent autoimmune diabetes in adults: an update].
    Zhou ZG; Li X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):630-4. PubMed ID: 14650175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunosuppression in Type I diabetes mellitus].
    Schönle EJ; Sizonenko PC; Spinas GA
    Schweiz Rundsch Med Prax; 1990 Oct; 79(41):1225-7. PubMed ID: 2237051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of residual beta cells and islet autoimmunity during increasing duration of diabetes in NOD mice and experimental approaches toward reversing new-onset disease with bioactive peptides.
    Reddy S; Cheung CC; Chai RC; Rodrigues JA
    Ann N Y Acad Sci; 2008 Dec; 1150():171-6. PubMed ID: 19120289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Latent autoimmune diabetes in adults].
    Maioli M; Puddu L; Pes GM
    Clin Ter; 2006; 157(1):69-78. PubMed ID: 16669554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes.
    Yang Z; Chen M; Carter JD; Nunemaker CS; Garmey JC; Kimble SD; Nadler JL
    Biochem Biophys Res Commun; 2006 Jun; 344(3):1017-22. PubMed ID: 16643856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of vitamin D in protecting type 1 diabetes mellitus.
    Luong Kv; Nguyen LT; Nguyen DN
    Diabetes Metab Res Rev; 2005; 21(4):338-46. PubMed ID: 15852446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Vitamin D on Islet Autoimmunity and Beta-Cell Function in Type 1 Diabetes.
    Infante M; Ricordi C; Sanchez J; Clare-Salzler MJ; Padilla N; Fuenmayor V; Chavez C; Alvarez A; Baidal D; Alejandro R; Caprio M; Fabbri A
    Nutrients; 2019 Sep; 11(9):. PubMed ID: 31514368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Will type I diabetes mellitus be treated with immunosuppressive drugs in the future?].
    Diem P
    Ther Umsch; 1993 Feb; 50(2):114-8. PubMed ID: 8456415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D and autoimmune diabetes.
    Zella JB; DeLuca HF
    J Cell Biochem; 2003 Feb; 88(2):216-22. PubMed ID: 12520517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D and type 1 diabetes mellitus: state of the art.
    Mathieu C; Badenhoop K
    Trends Endocrinol Metab; 2005 Aug; 16(6):261-6. PubMed ID: 15996876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Environmental factors in the development of type 1 diabetes -- a new insight].
    Płaczkiewicz-Jankowska E; Szybiński Z; Huszno B
    Przegl Lek; 2007; 64(3):175-9. PubMed ID: 17941471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy with GAD in diabetes.
    Ludvigsson J
    Diabetes Metab Res Rev; 2009 May; 25(4):307-15. PubMed ID: 19267332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-interleukin-1 in type 1 diabetes action trial--background and rationale.
    Pickersgill LM; Mandrup-Poulsen TR
    Diabetes Metab Res Rev; 2009 May; 25(4):321-4. PubMed ID: 19405081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current perspectives on vitamin D, immune system, and chronic diseases.
    Borges MC; Martini LA; Rogero MM
    Nutrition; 2011 Apr; 27(4):399-404. PubMed ID: 20971616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of vitamin D and dipeptidyl peptidase-4 inhibitors (VIDPP-4i) as an immunomodulation therapy for autoimmune diabetes.
    Pinheiro MM; Pinheiro FMM; Diniz SN; Fabbri A; Infante M
    Int Immunopharmacol; 2021 Jun; 95():107518. PubMed ID: 33756226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D and type 2 diabetes mellitus (D2).
    Xuan Y; Zhao HY; Liu JM
    J Diabetes; 2013 Sep; 5(3):261-7. PubMed ID: 23302127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.